Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -7.53x is 36% above its 3-year average of -11.81x, near the high end of its 3-year range (-45.31x–-5.12x).
17.21% below its 12-month average of -6.42x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -6.13x.
INTEREST COVERAGE RATIO
-7.53x
INTEREST COVERAGE RATIO AVG TTM
-6.42x
INTEREST COVERAGE RATIO AVG 3Y
-10.42x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-17.21%
CURRENT VS 3Y AVG
+27.70%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 331 covered companies
CURRENT VS SECTOR MEDIAN
-79.29%
vs the sector median at left
Adagio Medical Holdings, Inc.
Market Cap
$3.12M
Interest Coverage Ratio
-7.53x
TTM Avg
-6.42x
3Y Avg
-10.42x
5Y Avg
N/A
Market Cap
$3.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.35M
Interest Coverage Ratio
-507.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.37M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.75M
Interest Coverage Ratio
-238.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.36M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.62M
Interest Coverage Ratio
-4606.42x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | $3.12M | -7.53x | -6.42x | -10.42x | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.35M | -507.49x | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | N/A | N/A | N/A | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.75M | -238.27x | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.39M | -7.42x | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.36M | N/A | N/A | N/A | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.62M | -4606.42x | N/A | N/A | N/A |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | -81.61x | N/A | N/A | N/A |
Interest Coverage
-7.5x
Debt/Equity
N/A
Current Ratio
1.41
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -6.13x |
| 2026-03-31 | -6.68x |
| 2025-12-31 | -5.12x |
| 2025-09-30 | -7.64x |
| 2025-06-30 | -6.55x |
| 2025-03-31 | -11.17x |
| 2024-09-30 | -14.39x |
| 2024-06-30 | -8.76x |
| 2024-03-31 | -11.69x |
| 2023-12-31 | -9.24x |
| 2023-09-30 | -18.72x |
| 2023-06-30 | -18.88x |
| 2023-03-31 | -28.56x |
| 2022-12-31 | -45.31x |
